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Price Variation Analysis 
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Background & Project Overview 
Richard Slusky, 
 Director of Payment Reform GMCB 
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Background 
• The Green Mountain Care Board (GMCB) has been 
interested in the causes and consequences of health 
care price variation for several years. 
– The amount paid for a service can vary widely, depending on 
who is delivering the service, where it is delivered, and who is 
paying for it. 
• In 2012, the Board contracted with the Vermont 
Association of Hospitals and Health Systems to examine 
the magnitude of this variation. 
• That study identified wide variation in several 
dimensions, including in the amount an individual insurer 
paid an individual provider for a specific service. 
4 
Overview of this Project 
• In April, 2013, the Board issued an RFP for a 
more comprehensive examination of price 
variation, focusing on causes, consequences, 
and potential remedies. 
•  A contract was awarded to a team that included 
policy experts and economists from the 
University of Vermont and the University of 
Massachusetts Medical School. 
• This analysis looked at commercial payers and 
Medicaid.  Medicare data was not available. 
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Context for this Report 
• Confirm or refute that variation in payments exist 
• Identify potential causes of the variation 
• Recognize why this variation may be a problem 
in the context of payment reform 
• Identify principles, recommendations, and policy 
issues the GMCB should consider if they decide 
to address payment variation. 
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GMCB Role in Price Setting 
• Principles for establishing payment methods and 
rates must be in alignment with statutory 
requirements and principles 
– Chapter 220, Section 9376 requires the GMCB to “set 
reasonable rates…” 
– GMCB may consider legitimate differences in costs 
among health care professionals 
– The GMCB shall approve payment methodologies 
that encourage cost containment high quality 
services, and integration of care 
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Presentation of Report 
8 Global Health Economics Unit 
Center for Clinical and Translational Science 
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Key Terms 
• Charge: the amount billed by the provider. 
• Price: the total amount received by a provider, 
including what is paid by the insurer and what is 
paid by the patient.  This is determined 
contractually, and is often referred to as allowed 
charge or allowed amount. 
• Cost: the value of resources needed to provide 
the service (salaries, supplies, etc.) 
Global Health Economics Unit 
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NOTE:  This study did not explore the relationship 
between price and provider’s cost to deliver 
the service 
Key Terms (2) 
• Discounted charge: a method of establishing price 
based on a negotiated discount from charges.  This is 
most common in hospital payments. 
• Prospective payment system: payment method that 
establishes a fixed amount for a group of services.  The 
amount is independent of charges. Most common in 
hospital payment. 
• Fee schedule: a method of establishing prices based on 
a price schedule for individual services that is 
independent of charges.  This is most common in 
professional payments. 
Global Health Economics Unit 
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Methodology 
12 Global Health Economics Unit 
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Methodology 
• In order to develop a comprehensive picture, the team 
combined statistical analyses with stakeholder 
interviews. 
• Analyses relied on the state’s VHCURES claims data 
system. 
• Interviewees included both payers and providers, with a 
special focus on small physician practices. 
• The report contains a detailed discussion of 
methodology.  Additional information is available on 
request.  
Global Health Economics Unit 
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Discussion of Data Sources 
• This report relies heavily on VHCURES, the 
state’s claims database.  While the information 
in VHCURES is extremely useful, several 
caveats should be kept in mind. 
• Individual payers have not had an opportunity to 
verify information in VHCURES. 
• In our analyses, we relied on DRG assignments 
made by Onpoint, the state’s database contractor, 
rather than using DRGs submitted by the payers.  
This was necessary to ensure comparability, 
completeness, and accuracy. 
•     
Global Health Economics Unit 
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Discussion of Data Sources 
• Caveats (continued) 
• Data issues which may be relevant to the analyses 
in this report have been identified by other data 
users. 
• While we have made every effort to maximize data 
quality, statistical uncertainties remain. 
• Where appropriate, we have suppressed results 
based on small numbers to protect patient 
confidentiality and proprietary information. 
Global Health Economics Unit 
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Analysis of Price Variation:  Methods 
• Using statistical modeling, we estimated how well 
various factors explain the variation in commercial 
professional prices. 
– Identified factors that might explain price variation 
– Completed regression modeling to determine what 
percent of the variation could be explained by each of 
these factors 
16 Global Health Economics Unit 
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Analysis Findings 
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Analysis of Price Variation:  Findings 
There are many factors that explain why some health care 
providers are paid more than others for the same services: 
 
Global Health Economics Unit 
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Payer-Related Factors Provider-Related Factors 
Payer Provider Size 
Health Plan Product Provider Region 
Payment Method Provider Type 
Patient Share of Payment Site of Service 
Calendar Quarter Additional Service Detail 
Analysis of Price Variation:  Findings 
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Analysis of Price Variation:  Findings 
There is no consistency in the share of variation explained 
by each factor across services.  Factors explain different 
shares of variation for different services. Examples include: 
• Health Plan Product (e.g. HMO, PPO, POS) explains approximately half 
the variation in prices paid for an Evaluation & Management office visit 
for a patient age 40-64 
• Provider Type (e.g. primary care or specialty physician) explains 22% 
the variation in prices paid for a joint injection 
• Payment Method (e.g. fee schedule, charge, other) explains 20% of the 
variation in prices paid for a psychotherapy visit 
• Additional detail about the service provided explains 80% of the 
variation in prices paid for a mammogram 
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Analysis of Price Variation:  Findings 
Unexplained price variation might include: 
• a unique payment adjustment negotiated between a payer 
and a provider 
• an individual provider’s historical method for setting 
charges 
• a special circumstance that the payer did not report in the 
claims data for the specific service provided, for example a 
clinical condition that required far more resources than an 
average patient 
 
Global Health Economics Unit 
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Example of Price vs. Charge - 
Professional 
Global Health Economics Unit 
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One payer paid for one service based on charges, at least 4 different 
standard fees, and other unique payment methods 
CPT 99214 – Evaluation & Management Office Visit (25 minutes) 
 
Payers use fee 
schedules to 
standardize the price 
they pay to similar 
providers under similar 
circumstances.   
 
Note however that 
different payers may 
define “similar 
providers” and “similar 
circumstances” 
differently from each 
other.  
These boxplots demonstrate the clustering or skewness of datapoints.  The top and 
bottom of the boxes represent the first and third quartile prices.  The middle line 
represents the median price.  In cases where a payer pays the same price for a large 
share of visits, the median price may equal the first or third quartile price.  The diamond 
shape represents the mean price.  The “whiskers,” that is the top and bottom lines, 
represent the mean plus or minus one standard deviation.  The circles are outliers that 
are greater than one standard deviation from the mean price. 
Example of Price Variation 
CPT 99214, E&M Office Visit (25 minutes) by Health Plan Product 
All  health plan products pay 
a wide range of prices. 
 
The mean price, represented 
by the diamond, is highest for 
products with higher degrees 
of managed care (e.g. EPO, 
and HMO). 
 
Point of Service (POS) 
products require members to 
select a PCP but allow them 
to go out of network at higher 
cost-share. The dark circles 
(outliers) likely reflect out-of-
network payments. 
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Example of Price vs. Charge - Inpatient 
Global Health Economics Unit 
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Analysis of Price Variation:  Summary 
• There is substantial variation in price for both 
professional and hospital services. 
• Contributors to variation include payer size, payer 
type (public or private), provider size, provider type 
(e.g. private practice, FQHC, hospital-owned 
practice), specific product, payment mechanism 
(discount or PPS) and site of care. 
• The relative influence of these factors varies by type 
of service. 
Global Health Economics Unit 
Center for Clinical and Translational Science 
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Stakeholder Interviews 
26 Global Health Economics Unit 
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Stakeholder Interviews 
• Payers and hospitals typically negotiate an 
aggregate rate increase.  Negotiations may also 
address adjustments of fee schedules and 
quality reporting. 
• There is very little negotiation of prices between 
payers and most physician groups; most 
physician groups are “price takers.”  However, 
other aspects of the contract may be subject to 
negotiation. 
Global Health Economics Unit 
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Stakeholder Interviews (cont.) 
• The way that a price is calculated can contribute 
to price variation.  For example, some rates are 
set as a percentage discount from charges, 
while others are based on fee schedules. 
• Some contracts provide for lump sum payments 
that are not tied to individual claims.  These 
payments may come in the form of withholds, 
end of year settlements, or separately 
negotiated amounts, such as a fixed amount to 
support medical education. 
 
Global Health Economics Unit 
Center for Clinical and Translational Science 
28 
Stakeholder Interviews (cont.) 
• Both payers and providers reported that the 
GMCB hospital budget decisions play a 
significant role in hospital contract negotiations. 
However, there was a difference of opinion as to 
which side gains an advantage as a result of the 
regulatory process. 
 
Global Health Economics Unit 
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Recommendations 
30 Global Health Economics Unit 
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Strategic Recommendations:   
GMCB’s Next Steps 
1. Develop a set of principles for establishing payment 
methods and rates in alignment with the statutory 
requirements.  In developing these principles, seek input 
from advisory committees and other stakeholders. 
2. Develop draft payment methods and rates based on the 
principles. 
3. Model the impact of implementing consistent payment 
methods and rates statewide in terms of dollars gained 
or lost by individual health care providers, payers, as well 
as by state government and groups of consumers.   
Global Health Economics Unit 
Center for Clinical and Translational Science 
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Strategic Recommendations:   
GMCB’s Next Steps 
4. Develop a plan for phasing in standard methods and 
rates over time in order to buffer the initial effects and to 
give health care providers time to adjust their business 
practices to meet the new financial requirements 
5. Continue efforts to improve the accuracy and utility of 
VHCURES data. 
Global Health Economics Unit 
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Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
The next several slides list examples of principles that the 
GMCB could adopt for setting payment methods and rates.   
The principles listed are examples only, and the GMCB 
may wish to make substantive changes. 
However, the GMCB should consider adopting a principle 
that in some way addresses each of these topic areas. 
 
Global Health Economics Unit 
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Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
a. Process:  The GMCB will establish payment methods and rates in a 
fair, predictable, and transparent manner, consistent with statutory 
requirements. 
b. Cost level:  The GMCB will establish payment rates that are 
sufficient to meet the reasonable costs of an efficiently and 
economically operated provider and that takes into account the 
education, capital equipment, and other resources required to 
provide specific services. 
c. Basis of payment: The GMCB will establish an index payment per 
discharge for inpatient services and per visit for ambulatory 
services that will serve as the base for consistent payment rates 
statewide. 
  
Global Health Economics Unit 
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Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
d. Standard payment rate adjustments:  The GMCB will establish 
consistent payment rates statewide, except that the GMCB will 
adjust rates to reflect legitimate differences in costs related to:  
– providing a specific necessary service or services that may not be 
available elsewhere in the state, such as trauma services 
– the need for health care professionals in particular areas of the state, 
particularly in underserved geographic or practice shortage areas 
– access to primary care health services for underserved individuals, 
populations, and areas 
– a clinician’s licensure or certification 
– graduate medical education costs 
– support for Critical Access Hospitals, Federally Qualified Health Centers 
(FQHCs), FQHC lookalikes, Rural Health Clinics (RHCs) 
– charity care or bad debt 
Global Health Economics Unit 
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Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
e. Quality-based payment adjustments:  The GMCB may adjust 
payment rates to provide incentives for:  
• provision of high-quality, evidence-based health services in an 
integrated setting 
• patient self-management 
• healthy lifestyles  
f. Alternative payment methods:  The GMCB will allow providers to 
enter into agreements with payers to accept alternative payment 
methods, such as shared savings agreements, bundled payments, 
episode-based payments, and global payments, for providing high-
quality, evidence-based health services in an integrated setting.  
Global Health Economics Unit 
Center for Clinical and Translational Science 
36 
Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
g. Applicability of Payment Rates:  The GMCB will require all Vermont 
fully insured plans, and will encourage other payers, to pay 
providers using either the standard payment rates or alternative 
payment methods approved by the GMCB. Providers may charge 
no more than the GMCB established rates to individuals who pay 
out of pocket for health care services. 
h. Annual update factor:  The GMCB will increase rates annually by a 
factor no greater than the increase in Gross State Product, 
Consumer Price Index, or other standard.  The GMCB could 
consider holding the standard fee schedule to a lower rate of 
growth than alternative payment methods. 
 
Global Health Economics Unit 
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Examples of Strategic Rate Setting 
Principles for GMCB Consideration 
i. Phase-in period:  The GMCB will phase-in standard payment 
methods and rates over a period of three years. 
j. Transparency:  The GMCB will post standard payment methods 
and rates online on a consumer-friendly website and in formats that 
payers and providers can easily download and apply. 
 
Global Health Economics Unit 
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Additional Policy Questions 
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Additional Policy Questions from RFP 
1. Should payments based on discounts off charges be eliminated 
entirely?  If, so, what would replace them and over what period of 
time.  
A: Inpatient:  A substantial portion of inpatient care is currently paid for 
using DRGs.  While not all providers are paid by private insurers 
using DRGs, all providers are accustomed to DRG payments from 
Medicare and Medicaid.  This would be a fairly straightforward 
replacement for discounts.   
 Outpatient:  Our interviews and analysis indicated that less than 
half of professional services are paid for using fee schedule, and a 
smaller percent of hospital outpatient uses fee schedules.  Discount 
off charges appears to be a common practice, therefore careful 
modeling of a fee schedule basis of payment would be needed. 
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Additional Policy Questions from RFP 
 
2. Should FFS contracts always incorporate quality metrics into the 
negotiated reimbursement rates? 
A:  Provider contracts should include quality metrics.  Payers require 
providers to meet minimum quality standards in order to receive 
payment.  Additional payment for meeting or exceeding quality 
targets is usually paid separately, or incorporated into bundled or 
global payment amounts.  Quality metrics are generally not 
incorporated into FFS rates. 
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Additional Policy Questions from RFP 
 
3. Should those with high deductibles or the uninsured only be 
required to pay an amount for services that would be capped at 
some percentage above what Medicare or Medicaid would pay?  
A: It would be simpler for providers to administer a system where all 
payers, including individuals paying out of pocket, pay the same 
rates. 
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Additional Policy Questions from RFP 
 
4. Should the cost of medical education be carved out of the amount 
paid for hospital services and reimbursed separately through a 
negotiated budget amount that is shared by all payers?  
A: It would be administratively simpler for the GMCB to determine the 
total amount to be allocated for medical education and include it as 
an explicit adjustment to standard payment rates.  Otherwise, the 
GMCB would need to administer a separate system for collecting 
and remitting payment for medical education costs. 
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Additional Policy Questions from RFP 
5. Should higher payment for facility-based services that can be 
performed in a lower cost setting be eliminated entirely? 
A: Payment rates should not include incentives to provide services in 
a more costly environment.  Payment rates should be based on the 
reasonable costs of the education, capital equipment, and other 
resources required to provide the service.   
 However, standard payment rates may include adjustments to 
maintain certain facilities’ capacity to provide necessary services, 
such as emergency and trauma services or a specific necessary 
service that may not be available elsewhere in the state. 
   The cost of maintaining this capacity may be spread across 
payment rates for other services, resulting in higher payment rates 
for services provided in certain facilities than would be paid for 
those services when they are provided elsewhere. 
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Additional Policy Questions from RFP 
6. For all payers should annual updates be increased for evaluation 
and management codes, and updates for procedural diagnosis 
codes frozen for a period of three years, except for those that are 
demonstrated to be currently undervalued?  
A: The GMCB should establish fair and consistent payment methods 
and rates for health care services in Vermont, as well as a plan for 
phasing in these methods and rates over several years.   
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Questions? 
Global Health Economics Unit 
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